April 17 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* FY OPERATING REVENUES EUR 51.1 MLN VERSUS EUR 48.0 MLN PRO
FORMA
YEAR AGO
* FY EBITDA EUR 5.0 MLN VERSUS EUR 0.7 MLN PRO FORMA YEAR
AGO
* FY NET RESULT (EXCLUDING AMORTISATION OF GOODWILL)
BREAK-EVEN
VERSUS LOSS OF EUR 7.7 MLN PRO FORMA YEAR AGO
* CASH AVAILABLE AT END-FY EUR 11.0 MLN
* REITERATES OBJECTIVE OF 25 PERCENT REVENUE GROWTH BETWEEN
2017
AND 2020
Source text for Eikon: urn:newsml:reuters.com:*:nGNE7br0N5
Further company coverage: ALERS.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920))